STING

CAT # Sunan samfur Bayani
Saukewa: CPD101235 DIABZI STING agonist-1 trihydrochloride diABZI STING agonist-1 (trihydrochloride) wani zaɓi ne na agonist mai karɓa na interferon genes (STING), tare da EC50s na 130, 186 nM don mutum da linzamin kwamfuta, bi da bi.
Saukewa: CPD101234 diABZI STING agonist-1 (Tautomerism) diABZI STING agonist-1 Tautomerism (compound 3) wani zaɓi ne mai zaɓaɓɓen agonist mai karɓa na ƙwayoyin cuta na interferon (STING), tare da EC50s na 130, 186 nM don ɗan adam da linzamin kwamfuta, bi da bi.
Saukewa: CPD101233 diABZI STING agonist-1 diABZI STING agonist-1 zaɓi ne mai zaɓaɓɓen agonist mai karɓa na ƙwayoyin interferon (STING), tare da EC50s na 130, 186 nM don ɗan adam da linzamin kwamfuta, bi da bi.
Saukewa: CPD101232 STING agonist-4 STING agonist-4 shine mai kara kuzari na Interferon Genes (STING) agonist mai karɓa tare da tabbataccen inhibitory akai (IC50) na 20 nM. STING agonist-4 wani abu ne na amidobenzimidazole (ABZI) da ke da alaƙa guda biyu don ƙirƙirar ABZI mai alaƙa (diABZIs) tare da haɓaka haɓakawa zuwa STING da aikin salula.
Saukewa: CPD101231 STING agonist-3 STING agonist-3, wanda aka samo daga lamban kira WO2017175147A1 (misali 10), zaɓi ne kuma mara-nucleotide ƙananan ƙwayoyin STING agonist tare da pEC50 da pIC50 na 7.5 da 9.5, bi da bi. STING agonist-3 yana da tasirin anti-tumor mai dorewa da babban yuwuwar inganta maganin cutar kansa
da

Tuntube Mu

Tambaya

Sabbin Labarai

  • Manyan Abubuwa 7 A cikin Binciken Magunguna A cikin 2018

    Manyan Abubuwa 7 A Cikin Binciken Magunguna Na...

    Kasancewar kasancewa ƙarƙashin matsin lamba don yin gasa a cikin yanayi mai ƙalubale na tattalin arziki da fasaha, dole ne kamfanonin harhada magunguna da fasahar kere-kere su ci gaba da haɓaka cikin shirye-shiryensu na R&D don ci gaba ...

  • ARS-1620: Sabuwar mai hanawa don KRAS-mutant cancers

    ARS-1620: Sabuwar mai hanawa don K ...

    A cewar wani binciken da aka buga a cikin Cell, masu bincike sun kirkiro wani takamaiman mai hanawa don KRASG12C mai suna ARS-1602 wanda ya haifar da koma baya a cikin mice. "Wannan binciken yana ba da shaida a cikin vivo shaida cewa mutant KRAS na iya zama ...

  • AstraZeneca yana karɓar haɓakar tsari don magungunan oncology

    AstraZeneca yana karɓar haɓaka tsari don ...

    AstraZeneca ta sami haɓaka ninki biyu don fayil ɗin cutar sankara a ranar Talata, bayan hukumomin Amurka da na Turai sun karɓi ƙa'idodin ƙa'idodin magungunanta, matakin farko na samun amincewar waɗannan magunguna. ...

WhatsApp Online Chat!